Given the prevalence of EGFR mutations in adenocarcinoma among East Asian females who are never-smokers, it is hypothesized that higher parity might inversely affect lung cancer risk by inhibiting EGFR activation or mutation (50). This evidence concerns the gene EGFR and adenocarcinoma.